HIF1A and cancer: This atypical trend of increasing ROS activity was shown also by Zhao et al. who reported that inhibitors of HIF-1 inhibit reprogramming of cancer cell from OXPHOS to anaerobic glycolysis, increase intratumoral ROS production, and eventually supress the formation of metastatic tumours85.